Biocon Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

37 Stocks to buy right now

Join now and be among the first to discover Stock Ideas

Get the Stocks!

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1978

Chairman: Kiran Mazumdar-Shaw

Managing Director: Kiran Mazumdar-Shaw

Group: --

Listing: NSE: BIOCON, BSE: 532523

Headquarters: Bengaluru, Karnataka

Website: www.biocon.com

Key Facts

Market cap: R 35,304.00 Cr

Revenue (TTM): R 6,315.00 Cr

Earnings (TTM): R 986.90 Cr

Cash: R 1,886.50 Cr

Total Debt: R 2,423.00 Cr

Promoters' ownership: 60.67%

Liquidity: High

52 Week range: R 211.05 - 341.23

Face value: R5.00

Shares outstanding: 1,20,00,00,000

Stock Performance

Trailing
Annual

Time Period	Biocon	S&P BSE Mid Cap	S&P BSE Healthcare
YTD	0.20	4.90	5.04
1 month	3.03	5.93	5.36
3 months	13.94	9.07	9.68
1 Year	-12.23	5.50	0.28
3 Years	20.95	7.48	-1.51
5 Years	33.69	7.98	-1.88
10 Years	20.16	8.75	11.24

As on 23-Jan-2020

Year	Biocon	S&P BSE Mid Cap	S&P BSE Healthcare
2019	-6.14	-3.05	-3.55
2018	16.98	-13.31	-5.89
2017	69.70	48.13	0.49
2016	82.24	7.97	-12.88
2015	21.89	7.43	15.06
2014	-9.30	54.69	47.43
2013	59.96	-5.73	22.55

Annual Report (FY18)

Review & Analysis

Big shifts
Research Desk . 04-Jul-2018
Mr Contrarian
14-May-2018
Attractive Prospects
Research Desk . 08-Apr-2011
In The Pink Of Health
Research Desk . 20-May-2008

News & Announcements